BRESSANIN, DANIELA
Dettaglio
BRESSANIN, DANIELA
DIPARTIMENTO DI MEDICINA SPECIALISTICA, DIAGNOSTICA E SPERIMENTALE
Personale tecnico amm.vo
Pubblicazioni
Risultati 1 - 16 di 16 (tempo di esecuzione: 0.001 secondi).
Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File | |
---|---|---|---|---|---|---|---|
1 | A combination of temsirolimus, an allosteric mTOR inhibitor, with clofarabine as a new therapeutic option for patients with acute myeloid leukemia. | F. Chiarini; A. Lonetti; G. Teti; E. Orsini; D. Bressanin; A.Cappellini; F. Ricci; P. L. Tazzari;... A. Ognibene; M. Falconi; P. Pagliaro; I. Iacobucci; G. Martinelli; S. Amadori; J.A. McCubrey; A.M. Martelli. | 2012 | ONCOTARGET | 1.01 Articolo in rivista | - | |
2 | Activity of the Selective IκB kinase Inhibitor BMS-345541 against T-Cell Acute Lymphoblastic Leukemia: involvement of FOXO3a | F. Buontempo; F. Chiarini; D. Bressanin; G. Tabellini; F. Melchionda; A. Pession; M. Fini; L.M. N...eri; J.A. McCubrey; A.M. Martelli | 2012 | CELL CYCLE | 1.01 Articolo in rivista | - | |
3 | Cytotoxic activity of the novel Akt inhibitor, MK-2206, in T-cell acute lymphoblastic leukemia. | Simioni C; Neri LM; Tabellini G; Ricci F; Bressanin D; Chiarini F; Evangelisti C; Cani A; Tazzari... PL; Melchionda F; Pagliaro P; Pession A; McCubrey JA; Capitani S; Martelli AM. | 2012 | LEUKEMIA | 1.01 Articolo in rivista | - | |
4 | Harnessing the PI3K/Akt/mTOR pathway in T-cell acute lymphoblastic leukemia: Eliminating activity by targeting at different levels. | D. Bressanin; C. Evangelisti; F. Ricci; G. Tabellini; F. Chiarini; P.L. Tazzari; F. Melchionda; F.... Buontempo; P. Pagliaro; A. Pession; J.A. McCubrey; A.M. Martelli. | 2012 | ONCOTARGET | 1.01 Articolo in rivista | - | |
5 | MYCN is a novel oncogenic target in pediatric T-cell Acute Lymphoblastic Leukemia | A. Astolfi; F. Vendemini; M. Urbini; F. Melchionda; R. Masetti; M. Franzoni; V. Libri; S. Serrava...lle; M. Togni; L. Montemurro; R. Rondelli; G. Paone; D. Bressanin; F. Chiarini; A.M. Martelli; R. Tonelli; A. Pession. | 2014 | ONCOTARGET | 1.01 Articolo in rivista | - | |
6 | Nuclear phosphoinositides and their roles in cell biology and disease. | Martelli A.M.; Ognibene A.; Buontempo F.; Fini M.; Bressanin D.; Goto K.; McCubrey J.A.; Cocco L....; Evangelisti C. | 2011 | CRITICAL REVIEWS IN BIOCHEMISTRY AND MOLECULAR BIOLOGY | 1.01 Articolo in rivista | - | |
7 | Proteolysis of the proofreading subunit controls the assembly of Escherichia coli DNA polymerase III catalytic core. | Bressanin D.; Stefan A.; Dal Piaz F.; Cianchetta S.; Reggiani L.; Hochkoeppler A. | 2009 | BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS | 1.01 Articolo in rivista | - | |
8 | Spermidine application to young developing peach fruits leads to a slowing down of ripening by impairing ripening-related ethylene and auxin metabolism and signaling | P. Torrigiani; D. Bressanin; K. Ruiz Carrasco; A. Tadiello; L. Trainotti; C. Bonghi; V. Ziosi; G.... Costa | 2012 | PHYSIOLOGIA PLANTARUM | 1.01 Articolo in rivista | - | |
9 | Stabilization of the Escherichia coli DNA polymerase III epsilon subunit by the theta subunit favors in vivo assembly of the Pol III catalytic core | Conte E; Vincelli G; Schaaper RM; Bressanin D; Stefan A; Dal Piaz F; Hochkoeppler A | 2012 | ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS | 1.01 Articolo in rivista | - | |
10 | Targeting phosphatidylinositol 3-kinase signaling in acute myelogenous leukemia. | C. Evangelisti; C. Evangelisti; D. Bressanin; F. Buontempo; F. Chiarini; A Lonetti; M Soncin; A.M.... Spartà; J. A. McCubrey; A.M. Martelli. | 2013 | EXPERT OPINION ON THERAPEUTIC TARGETS | 1.01 Articolo in rivista | - | |
11 | Targeting signaling pathways in T-cell acute lymphoblastic leukemia initiating cells. | A.M. Martelli; A. Lonetti; F. Buontempo; F. Ricci; P.L. Tazzari; C. Evangelisti; D. Bressanin; A.... Cappellini; E. Orsini; F. Chiarini. | 2014 | ADVANCES IN BIOLOGICAL REGULATION | 1.01 Articolo in rivista | - | |
12 | Targeting the liver kinase B1/AMP-activated protein kinase pathway as a therapeutic strategy for hematological malignancies | Alberto M Martelli;Francesca Chiarini;Camilla Evangelisti;Andrea Ognibene;Daniela Bressanin;Anna ...Maria Billi;Lucia Manzoli;Alessandra Cappellini;James A McCubrey | 2012 | EXPERT OPINION ON THERAPEUTIC TARGETS | 1.01 Articolo in rivista | - | |
13 | The emerging multiple roles of nuclear Akt. | A.M. Martelli; G. Tabellini; D. Bressanin; A. Ognibene; K. Goto; L. Cocco; C. Evangelisti. | 2012 | BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH | 1.01 Articolo in rivista | - | |
14 | Therapeutic potential of targeting mTOR in T-cell acute lymphoblastic leukemia | Camilla Evangelisti; Cecilia Evangelisti; Francesca Chiarini; Annalisa Lonetti; Francesca Buontem...po; Daniela Bressanin; Alessandra Cappellini; Ester Orsini; James A. McCubrey; Alberto Maria Martelli. | 2014 | INTERNATIONAL JOURNAL OF ONCOLOGY | 1.01 Articolo in rivista | - | |
15 | Therapeutic targeting of polo-like kinase-1 and Aurora kinases in T-cell acute lymphoblstic leukemia. | A.M. Spartà; D. Bressanin; F. Chiarini; A. Lonetti; A. Cappellini; C. Evangelisti; C. Evangelisti...; F. Melchionda; A. Pession; A. Bertaina; F. Locatelli; J.A. McCubrey; A.M. Martelli. | 2014 | CELL CYCLE | 1.01 Articolo in rivista | - | |
16 | Two hits are better than one: targeting both phosphatidylinositol 3-kinase and mammalian target of rapamycin as a therapeutic strategy for acute leukemia treatment. | A.M. Martelli; F. Chiarini; C. Evangelisti; A. Cappellini; F. Buontempo; D. Bressanin; M. Fini; J....A. McCubrey | 2012 | ONCOTARGET | 1.01 Articolo in rivista | - |